p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.
about
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma.Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis.
P2860
p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
p53 gene therapy-based transar ...... a: A prospective cohort study.
@en
type
label
p53 gene therapy-based transar ...... a: A prospective cohort study.
@en
prefLabel
p53 gene therapy-based transar ...... a: A prospective cohort study.
@en
P2093
P2860
P356
P1476
p53 gene therapy-based transar ...... a: A prospective cohort study.
@en
P2093
Hejun Deng
Qingdong Li
Shihong Liu
Weiqian Yu
P2860
P304
P356
10.1111/JGH.13009
P577
2015-05-13T00:00:00Z